These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27678079)

  • 1. The cost-effectiveness of hospital-based telephone coaching for people with type 2 diabetes: a 10 year modelling analysis.
    Varney JE; Liew D; Weiland TJ; Inder WJ; Jelinek GA
    BMC Health Serv Res; 2016 Sep; 16(1):521. PubMed ID: 27678079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-effectiveness analysis of a telephone-linked care intervention for individuals with Type 2 diabetes.
    Gordon LG; Bird D; Oldenburg B; Friedman RH; Russell AW; Scuffham PA
    Diabetes Res Clin Pract; 2014 Apr; 104(1):103-11. PubMed ID: 24503043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis for a tele-based health coaching program for chronic disease in primary care.
    Oksman E; Linna M; Hörhammer I; Lammintakanen J; Talja M
    BMC Health Serv Res; 2017 Feb; 17(1):138. PubMed ID: 28202032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a telephone-delivered intervention for physical activity and diet.
    Graves N; Barnett AG; Halton KA; Veerman JL; Winkler E; Owen N; Reeves MM; Marshall A; Eakin E
    PLoS One; 2009 Sep; 4(9):e7135. PubMed ID: 19779611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hospital-based telephone coaching on glycaemic control and adherence to management guidelines in type 2 diabetes, a randomised controlled trial.
    Varney JE; Weiland TJ; Inder WJ; Jelinek GA
    Intern Med J; 2014 Sep; 44(9):890-7. PubMed ID: 24963611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Analysis of a Diabetes Health Coaching Intervention for Adults Living With Type 2 Diabetes: A Single-Centre Evaluation From a Community-Based Randomized Controlled Trial.
    O'Reilly DJ; Blackhouse G; Bowen JM; Brozic A; Agema P; Punthakee Z; McInnes N; Gerstein HC; Sherifali D
    Can J Diabetes; 2022 Mar; 46(2):165-170. PubMed ID: 35115250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management.
    Grustam AS; Severens JL; De Massari D; Buyukkaramikli N; Koymans R; Vrijhoef HJM
    Value Health; 2018 Jul; 21(7):772-782. PubMed ID: 30005749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost effectiveness study of integrated care in health services delivery: a diabetes program in Australia.
    McRae IS; Butler JR; Sibthorpe BM; Ruscoe W; Snow J; Rubiano D; Gardner KL
    BMC Health Serv Res; 2008 Oct; 8():205. PubMed ID: 18834551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis.
    Gillett M; Dallosso HM; Dixon S; Brennan A; Carey ME; Campbell MJ; Heller S; Khunti K; Skinner TC; Davies MJ
    BMJ; 2010 Aug; 341():c4093. PubMed ID: 20729270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Three Doses of a Behavioral Intervention to Prevent or Delay Type 2 Diabetes in Rural Areas.
    Radcliff TA; Côté MJ; Whittington MD; Daniels MJ; Bobroff LB; Janicke DM; Perri MG
    J Acad Nutr Diet; 2020 Jul; 120(7):1163-1171. PubMed ID: 31899170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of general practice based, practice nurse led telephone coaching on glycaemic control of type 2 diabetes: the Patient Engagement and Coaching for Health (PEACH) pragmatic cluster randomised controlled trial.
    Blackberry ID; Furler JS; Best JD; Chondros P; Vale M; Walker C; Dunning T; Segal L; Dunbar J; Audehm R; Liew D; Young D
    BMJ; 2013 Sep; 347():f5272. PubMed ID: 24048296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets.
    Valentine WJ; Palmer AJ; Nicklasson L; Cobden D; Roze S
    Int J Clin Pract; 2006 Sep; 60(9):1138-45. PubMed ID: 16939559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial.
    Wild S; Hanley J; Lewis S; McKnight J; McCloughan L; Padfield P; Paterson M; Pinnock H; McKinstry B
    Trials; 2013 Jul; 14():198. PubMed ID: 23829417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of a cluster-randomized, culturally tailored, community health worker home-visiting diabetes intervention versus standard care in American Samoa.
    Huang SJ; Galárraga O; Smith KA; Fuimaono S; McGarvey ST
    Hum Resour Health; 2019 Mar; 17(1):17. PubMed ID: 30836964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial.
    Tao L; Wilson EC; Wareham NJ; Sandbaek A; Rutten GE; Lauritzen T; Khunti K; Davies MJ; Borch-Johnsen K; Griffin SJ; Simmons RK
    Diabet Med; 2015 Jul; 32(7):907-19. PubMed ID: 25661661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.
    Shaw L; Bhattarai N; Cant R; Drummond A; Ford GA; Forster A; Francis R; Hills K; Howel D; Laverty AM; McKevitt C; McMeekin P; Price C; Stamp E; Stevens E; Vale L; Rodgers H
    Health Technol Assess; 2020 May; 24(24):1-202. PubMed ID: 32468989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial.
    Warren R; Carlisle K; Mihala G; Scuffham PA
    J Telemed Telecare; 2018 Oct; 24(9):586-595. PubMed ID: 28814128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes.
    Palmer AJ; Roze S; Lammert M; Valentine WJ; Minshall ME; Nicklasson L; Gall MA; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S41-51. PubMed ID: 15324515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.
    Valentine WJ; Bottomley JM; Palmer AJ; Brändle M; Foos V; Williams R; Dormandy JA; Yates J; Tan MH; Massi-Benedetti M;
    Diabet Med; 2007 Sep; 24(9):982-1002. PubMed ID: 17593245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.